Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Wagner

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
American Heart Journal|November 18, 2005
Economic impact of the reduced incidence of atrial fibrillation in patients with heart failure treated with enalaprilMonika Wagner, Donna Rindress, Brigitte Desjardins, et al.
BMC Cancer|April 18, 2017
Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDAMonika Wagner, Hanane Khoury, Liga Bennetts, et al.
Cost Effectiveness and Resource Allocation : C/E|April 10, 2010
Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patientsMireille M Goetghebeur, Monika Wagner, Hanane Khoury, et al.
Infectious Agents and Cancer|May 20, 2015
Global availability of data on HPV genotype-distribution in cervical, vulvar and vaginal disease and genotype-specific prevalence and incidence of HPV infection in femalesMonika Wagner, Liga Bennetts, Harshila Patel, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|June 18, 2009
Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in CanadaMonika Wagner, Mireille Goetghebeur, Elizabeth Merikle, et al.
BMC Health Services Research|December 2, 2011
Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in CanadaMichèle Tony, Monika Wagner, Hanane Khoury, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 12, 2011
Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisalMireille M Goetghebeur, Monika Wagner, Hanane Khoury, et al.
BMC Health Services Research|December 24, 2008
Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applicationsMireille M Goetghebeur, Monika Wagner, Hanane Khoury, et al.
Advances in Therapy|July 11, 2018
Applying Reflective Multicriteria Decision Analysis (MCDA) to Patient-Clinician Shared Decision-Making on the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the Spanish ContextMonika Wagner, Dima Samaha, Jesus Cuervo, et al.
Annals of Family Medicine|March 1, 2023
Identifying value arguments and deployment avenues of primary care innovations using a deliberative multidimensional approachBenoît Corriveau, Emilie Dufour, Marie-Pascale Pomey, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
American Heart Journal|November 18, 2005
Economic impact of the reduced incidence of atrial fibrillation in patients with heart failure treated with enalaprilMonika Wagner, Donna Rindress, Brigitte Desjardins, et al.
BMC Cancer|April 18, 2017
Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDAMonika Wagner, Hanane Khoury, Liga Bennetts, et al.
Cost Effectiveness and Resource Allocation : C/E|April 10, 2010
Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patientsMireille M Goetghebeur, Monika Wagner, Hanane Khoury, et al.
Infectious Agents and Cancer|May 20, 2015
Global availability of data on HPV genotype-distribution in cervical, vulvar and vaginal disease and genotype-specific prevalence and incidence of HPV infection in femalesMonika Wagner, Liga Bennetts, Harshila Patel, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|June 18, 2009
Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in CanadaMonika Wagner, Mireille Goetghebeur, Elizabeth Merikle, et al.
BMC Health Services Research|December 2, 2011
Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in CanadaMichèle Tony, Monika Wagner, Hanane Khoury, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 12, 2011
Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisalMireille M Goetghebeur, Monika Wagner, Hanane Khoury, et al.
BMC Health Services Research|December 24, 2008
Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applicationsMireille M Goetghebeur, Monika Wagner, Hanane Khoury, et al.
Advances in Therapy|July 11, 2018
Applying Reflective Multicriteria Decision Analysis (MCDA) to Patient-Clinician Shared Decision-Making on the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the Spanish ContextMonika Wagner, Dima Samaha, Jesus Cuervo, et al.
Annals of Family Medicine|March 1, 2023
Identifying value arguments and deployment avenues of primary care innovations using a deliberative multidimensional approachBenoît Corriveau, Emilie Dufour, Marie-Pascale Pomey, et al.
Pageof 4